>
Windows 10 is DEAD in 2025? -- Here's How I Run It SAFELY Forever (No Updates)
GENIUS ACT TRIGGERED: The Biggest BANK RUN in History is COMING – Prepare NOW
European Billionaires Funneled $2 Billion into NGO Network to Fund Anti-Trump Protest Machine
Japan Confirms Over 600,000 Citizens Killed by COVID mRNA 'Vaccines'
Japan just injected artificial blood into a human. No blood type needed. No refrigeration.
The 6 Best LLM Tools To Run Models Locally
Testing My First Sodium-Ion Solar Battery
A man once paralyzed from the waist down now stands on his own, not with machines or wires,...
Review: Thumb-sized thermal camera turns your phone into a smart tool
Army To Bring Nuclear Microreactors To Its Bases By 2028
Nissan Says It's On Track For Solid-State Batteries That Double EV Range By 2028
Carbon based computers that run on iron
Russia flies strategic cruise missile propelled by a nuclear engine
100% Free AC & Heat from SOLAR! Airspool Mini Split AC from Santan Solar | Unboxing & Install

This exciting new study shows that "proton therapy" is a stunningly effective noninvasive treatment against high-risk childhood cancers – and it comes with minimal side effects.
Unlike traditional photon radiation using x-rays, proton radiation therapy (PRT) is a non-invasive, precise cancer treatment that uses a beam of protons moving at very high speeds to destroy the DNA of cancer cells, killing them and preventing them from multiplying.
Highly targeted, PRT has significant promise for treating tumors in very young children and may reduce radiation exposure to healthy, developing tissue that may result in lifelong impacts.
Researchers from Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania analyzed the largest cohort to date of pediatric patients with high-risk neuroblastoma who were treated with proton radiation therapy.
Not only did they find that proton therapy was effective at reducing tumors, they also found that it demonstrated minimal toxicity to surrounding organs.
The study is published online in the International Journal of Radiation Oncology.
"These data are extremely encouraging and could be a game-changer for a number of reasons," said lead author Christine Hill-Kayser, Chief of the Pediatric Radiation Oncology Service at Penn Medicine.